TMCnet News
Digital Health Market 2020-2030: Focus on Digital Therapeutics by Type of Solution, Type of Therapy and Purpose of SolutionDUBLIN, Nov. 5, 2020 /PRNewswire/ -- The "Digital Health Market: Focus on Digital Therapeutics (2nd Edition), 2020-2030: Based on Type of Solution, Type of Therapy and Purpose of Solution" report has been added to ResearchAndMarkets.com's offering. The report features an extensive study of the current landscape, offering an informed opinion on the likely adoption of digital therapeutics solutions (either commercialized or under development) in the healthcare industry, over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. One of the key objectives of the report was to estimate the existing market size and the future opportunity for digital therapeutics developers over the next decade. Based on multiple parameters, likely adoption trends, and expected price variations for these products, we have provided an informed estimate of the evolution of the market for the period 2020-2030.
Key Topics Covered: 1. PREFACE 4.2.5. Analysis by Target Disease Indication(s) 4.2.6. Analysis by Therapeutic Area 4.2.7. Analysis by Target Population 4.3. Digital Therapeutics: Additional Information 4.3.1. Analysis by Prescription Requirement 4.3.2. Analysis by Duration of Course 4.3.3. Analysis by Cost of Solution 4.4. Digital Therapeutics: List of Developers 4.4.1. Analysis by Year of Establishment 4.4.2. Analysis by Company Size 4.4.3. Analysis by Type of Business Model 4.4.4 Analysis by Location of Headquarters 4.5. Leading Developers: Analysis by Number of Digital Therapeutics Solutions 4.6. Leading Developers: 4D Bubble Analysis based on Portfolio Strength, Target Indication and Company Size 4.7. Grid Representation: Analysis by Status of Development, Type of Solution and Therapeutic Area 4.8. Tree Map Representation: Analysis by Therapeutic Area and Company Size 4.9. World Map Representation: Analysis of Regional Activity 4.10. Digital Therapeutics: Information on Additional Companies 5. PRODUCT COMPETITIVENESS ANALYSIS 5.1. Chapter Overview 5.2. Methodology 5.3. Assumptions / Key Parameters 5.4. Key Therapeutic Areas 5.4.1. Cardiovascular Disorders 5.4.2. Mental Health Problems 5.4.3. Metabolic Disorders 5.4.4. Neurological Disorders 5.4.5. Substance Use Disorders 5.4.6. Other Therapeutic Areas 6. COMPANY PROFILES 6.1. Chapter Overview 6.2. Akili Interactive 6.2.1 Company Overview 6.2.2. Product Portfolio 6.2.3. Recent Developments and Future Outlook 6.3. Big Health 6.4. dreem 6.5 Kaia Health 6.6. Mindmaze 6.7. Omada Health 6.8. Pear Therapeutics 6.9. Vida Health 6.10. Voluntis 6.11. WellDoc 6.12. Wellthy Therapeutics 7. CLINICAL TRIAL ANALYSIS 7.1. Chapter Overview 7.2. Scope and Methodology 7.3. Digital Therapeutics: Clinical Trial Analysis 7.3.1. Analysis by Trial Registration Year 7.3.2. Analysis by Trial Phase 7.3.3. Analysis by Number of Patients Enrolled and Trial Registration Year 7.3.4. Analysis by Study Design 7.3.5. Analysis by Trial Recruitment Status 7.3.6. Analysis by Sponsor / Collaborator 7.3.7. Leading Industry Players: Analysis by Number of Registered Trials 7.3.8 Leading Digital Therapeutic Solutions: Analysis by Number of Registered Trials 7.3.9. Analysis by Trial Focus 7.3.10. Analysis by Therapeutic Area 7.3.11. Geographical Analysis by Number of Clinical Trials 7.3.12. Geographical Analysis by Trial Recruitment Status 7.3.13. Geographical Analysis by Enrolled Patient Population 7.4. Clinical End-Points Analysis 8. FUNDING AND INVESTMENT ANALYSIS 8.1. Chapter Overview 8.2. Types of Funding 8.3. Digital Therapeutics: Funding and Investment Analysis 8.3.1. Analysis by Number of Funding Instances 8.3.2. Analysis by Amount Invested 8.3.3. Analysis by Type of Funding 8.3.4. Analysis by Type of Therapy 8.3.5. Analysis by Therapeutic Area 8.3.6. Analysis by Geography 8.3.7. Most Active Players: Analysis by Number of Funding Instances 8.3.8. Most Active Players: Analysis by Amount of Funding 8.3.9. Most Active Investors: Analysis by Number of Instances 8.4 Concluding Remarks 9. PARTNERSHIPS AND COLLABORATIONS 9.1. Chapter Overview 9.2. Partnership Models 9.3. Digital Therapeutics: Recent Partnerships and Collaborations 10. GO-TO-MARKET STRATEGY 10.1. Chapter Overview 10.2. Marketing Strategies Adopted by Digital Therapeutic Developers 10.2.1. Participation in Global Events 10.2.2. Marketing on Social Media Platforms 10.2.3. Marketing on Online / Print Media Platforms 10.2.4. Undertaking Various Promotional Activities through Official Websites 10.2.5. Adoption of Different Business Models and Pricing Strategies 10.2.5.1. B2C Business Model 10.2.5.2. B2B Business Model 10.2.5.2. B2B2C Business Model 10.2.6. Undertaking Various Promotional Activities through Product Add-ons 10.3. Concluding Remarks 11. BOWMAN CLOCK PRICING STRATEGY ANALYSIS 11.1. Chapter Overview 11.2. Bowman Strategy Clock 11.2.1. Two Dimensions of Bowman Strategy Clock 11.2.2. Eight Positions on Bowman Strategic Clock 11.3 Framework 11.3.1. Methodology 11.3.2. Theoretical Framework and Price Evaluation Hypothesis 11.3.3. Results and Interpretation 11.4. Concluding Remarks 12. MARKET FORECAST 13. CASE STUDY: IMPACT OF CORONAVIRUS OUTBREAK 13.1. Chapter Overview 13.2. Impact of Coronavirus Pandemic on Digital Therapeutics 13.2.1. Impact on Future Market Opportunity for Digital Therapeutic Solutions Market 13.3. Recuperative Strategies for Developer Businesses 13.3.1. Strategies for Implementation in the Short / Mid Term 13.3.2. Strategies for Implementation in the Long Term 14. REMOTE DIGITAL MONITORING / DIAGNOSTIC SOLUTIONS 14.1. Chapter Overview 14.2. An Introduction to Remote Digital Monitoring / Diagnostic Solutions 14.3. Remote Digital Monitoring / Diagnostic Solutions: Overall Market Landscape 14.4. Remote Digital Monitoring / Diagnostic Solutions: List of Developers 14.5. Remote Digital Monitoring / Diagnostic Solutions: Company Profiles 14.6. Remote Digital Monitoring / Diagnostic Solutions: Funding and Investment Analysis 14.7. Concluding Remarks 15. SWOT ANALYSIS 15.1. Chapter Overview 15.2. Comparison of SWOT Factors 15.2.1. Strengths 15.2.2. Weaknesses 15.2.3. Opportunities 15.2.4. Threats 16. DIGITAL SOLUTIONS: RECENT TRENDS AND FUTURE OPPORTUNITIES 16.1. Chapter Overview 16.2. Prevalent Trends Related to Digital Therapeutics 16.2.1. Emerging Focus Areas 16.2.2. Key Historical Trends 16.2.3. Geographical Distribution of Activity 16.3. Trends Shaping the Future of Digital Therapeutics 16.3.1. Digital Solutions Closing the Digital Gap 16.3.2. Increasing Focus on Patient Centric Models 16.3.3. Applicability across a Variety of Disease Indications 16.3.4. Increasing Emphasis on Real-World Evidence in Research and Development 16.3.5. Advances in IT and Computing Power to Foster Future Innovation 16.4. Improving the Future Health: Opportunities Beyond Digital Therapeutics 17. EXECUTIVE INSIGHTS For more information about this report visit https://www.researchandmarkets.com/r/4k69q Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. Media Contact: Research and Markets View original content:http://www.prnewswire.com/news-releases/digital-health-market-2020-2030-focus-on-digital-therapeutics-by-type-of-solution-type-of-therapy-and-purpose-of-solution-301167030.html SOURCE Research and Markets |